Eagle Pharmaceuticals, Inc. Asset Impairment Charges
Eagle Pharmaceuticals, Inc. reported Asset Impairment Charges of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2021-03-05
- Eagle Pharmaceuticals, Inc. asset impairment charges for the quarter ending 2019-12-31 was $0.00.
- Eagle Pharmaceuticals, Inc. asset impairment charges for the quarter ending 2019-09-30 was $0.00.
- Eagle Pharmaceuticals, Inc. asset impairment charges for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. asset impairment charges for the quarter ending 2018-12-31 was $0.00.
- Eagle Pharmaceuticals, Inc. asset impairment charges for fiscal 2020 was $0.00.
- Eagle Pharmaceuticals, Inc. asset impairment charges for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Eagle Pharmaceuticals, Inc. asset impairment charges for fiscal 2018 was $2.70M, a 62.63% decline from fiscal 2017.
- Eagle Pharmaceuticals, Inc. asset impairment charges for fiscal 2017 was $7.24M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $0.00 derived: sum of 2 quarters · filed 2021-03-05 | $0.00 derived: sum of 3 quarters · filed 2021-03-05 | $0.00 10-K · filed 2021-03-05 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $0.00 derived: sum of 2 quarters · filed 2021-03-05 | $2.70M derived: sum of 3 quarters · filed 2021-03-05 | $2.70M 10-K · filed 2021-03-05 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $2.70M derived: sum of 2 quarters · filed 2019-11-12 | $2.70M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $2.70M 10-Q · filed 2019-08-08 | $2.70M 10-Q · filed 2019-08-08 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $7.24M derived: sum of 2 quarters · filed 2020-03-02 | $7.24M derived: sum of 3 quarters · filed 2020-03-02 | $7.24M 10-K · filed 2020-03-02 |
| 2017-09-30 | $7.24M 10-Q · filed 2018-11-01 | $7.24M derived: sum of 2 quarters · filed 2018-11-01 | $7.24M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-26 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 |